Sirona Biochem Appoints Casper Bych To Its Board of Directors

Vancouver, British Columbia – June 26, 2015 – Sirona Biochem Corp. (“Sirona”) or the (“Company”) (TSX-V: SBM) (FSE: ZSB) is pleased to announce the appointment of Mr. Casper Bych to its Board of Directors.

Mr. Bych has more than 20 years’ experience in management and in the legal and financial industry in Europe, South and North America. Casper is the President and CEO of Mountainview Capital Corporation, a Vancouver based corporate finance boutique that raises funds for public companies, private cash flow companies and private companies in the process of going public. Mountainview Capital has acted for companies in the resource sector, energy and medical device sectors in North and South America. Mountainview Capital also provides financial advisory services in connection with project financings and acts as management consultant for companies in the process of going public or undergoing M&A transactions.

Prior to founding Mountainview Capital, Mr. Bych was a securities lawyer in Vancouver. His practice was primarily focused on the healthcare, resource and technology sector, where he took companies public and acted for publicly traded companies.

Mr. Bych holds law degrees from University of Copenhagen (Cand Jur) and McGill University.

The Company also announces that Mr. Nigel Terrett has resigned as a director. The Company’s thanks Mr. Terrett for his work over the past few years.

The Company also announces that it has granted incentive stock options under its stock option plan to directors, officers and employees of the company for the purchase of 4,200,000 common shares of the Company at a price of $0.16 per share. 3,600,000 of the options are for a ten year period, 600,000 are for a two year period.

For more information regarding this press release, please contact:

Christopher Hopton, CFO
Sirona Biochem Corp.
Phone: 1.604.282.6064

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

About Sirona Biochem

Sirona Biochem is a cosmetic ingredient and drug discovery company with a proprietary technology platform developed at its laboratory facility in France. The company specializes in the stabilization of carbohydrate molecules, with the goal of improving compounds’ efficacy and safety. Sirona Biochem’s compounds are patented as new chemical entities for maximum commercial protection and revenue potential. Newly developed compounds are licensed to leading companies around the world in return for licensing and milestone fees and ongoing royalty payments. TFChem, Sirona Biochem’s wholly-owned French laboratory is a recipient of multiple French national scientific awards and a European Union and French government grant. For more information visit .

Help employers find you! Check out all the jobs and post your resume.

Back to news